IL17A and tuberculosis: Our findings were in agreement with the previous finding that DMTB patients show increased inflammatory responses[2,33,35,36] compared to TB patients: expression levels of genes in multiple inflammatory pathways or activities, namely “myeloid leukocyte activation,” “signaling by interleukins,” “leukocyte differentiation” and “IL-17 signaling” increased in DMTB patients relative to TB patients (Fig. 4C).